BVS vs FAST · rev $573.3M vs P/E 43, rev $7.55B
Bioventus Inc (BVS) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
BVS currently screens at market cap $495.1M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the BVS and FAST stock pages for the full models.
Not investment advice.